Grantees
Our comprehensive, hypothesis-driven approach breaks down barriers between innovation, scientific findings, and clinical care. Our grantees support and drive our mission to help everyone with bipolar disorder thrive.
Grantee Projects
Showing 16 of 26 results.
BD² Integrated Network – Johns Hopkins University
Southern USBD² Integrated Network – Mass General Brigham
Northeastern USBD² Integrated Network – Mayo Clinic
Midwestern USBD² Integrated Network – The Feinstein Institutes for Medical Research
Northeastern USBD² Integrated Network – The University of Texas at Austin
Southwestern USBD² Integrated Network – The University of Texas Health Science Center at Houston
Southwestern USBD² Integrated Network – University of California Los Angeles
Western USBD² Integrated Network – University of California San Diego
Western USBD² Integrated Network – University of Cincinnati/Lindner Center of HOPE
Midwestern USBD² Integrated Network – University of Michigan
Midwestern USBD² Integrated Network Clinical Coordinating Center (CCC)
The Feinstein Institutes for Medical ResearchBD² Integrated Network Data Coordinating Center & Centralized Repository (DCC)
Indoc ResearchBipolar Disorder Genes In Brain Circuits Controlling Sleep and Wake Cycles
Julie Kauer, PhDTeam Institutions
- Stanford University
- Northwestern University
- University of Texas Austin
Brain Omics Platform
The CommonMind ConsortiumTeam Institutions
- Icahn School of Medicine at Mount Sinai
- University of Pittsburgh
- California Institute of Technology
CircaVent: A Drug Prediction and Discovery Platform for Bipolar Disorder
Jenny Tam, PhDTeam Institution
- Wyss Institute at Harvard University
Drug Prediction and Validation from Single Cell Multi-Omics in Brain Organoid Systems
Team Institutions
- Wyss Institute at Harvard University
- Icahn School of Medicine at Mount Sinai